UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051277
Receipt number R000058128
Scientific Title The effect of NP-FES (Neuroprosthetic functional electrical stimulation) on upper limb vascular function in elderly patients with hemiplegia
Date of disclosure of the study information 2023/06/08
Last modified on 2023/06/07 12:18:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of NP-FES (Neuroprosthetic functional electrical stimulation) on upper limb vascular function in elderly patients with hemiplegia

Acronym

The effect of NP-FES (Neuroprosthetic functional electrical stimulation) on upper limb vascular function in elderly patients with hemiplegia

Scientific Title

The effect of NP-FES (Neuroprosthetic functional electrical stimulation) on upper limb vascular function in elderly patients with hemiplegia

Scientific Title:Acronym

The effect of NP-FES (Neuroprosthetic functional electrical stimulation) on upper limb vascular function in elderly patients with hemiplegia B

Region

Japan


Condition

Condition

stroke

Classification by specialty

Cardiology Neurology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the effects of continuous Neuroprosthetic functional electrical stimulation (NP-FES) on peripheral circulatory function in living-phase hemiplegics.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Venous vessel width (before and after energization) Measurements at baseline, 1 week, 2 weeks, 3 weeks, and 4 weeks after intervention 1 and intervention 2 for 2 cools.

Key secondary outcomes

Skin surface temperature, venous oxygenation index, estimated hemoglobin level (before and after energization) Measurements at baseline, 1, 2, 3, and 4 weeks after intervention 1 and intervention 2 for 2 cools.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Cluster

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Intervention 1: Dorsiflexion movement with energization under 70 Hz conditions for 4 minutes. The rhythm of the energization consists of 2 seconds of energization and 2 seconds of rest. This will be performed twice a week. The washout period will be 2 weeks. The intensity of the stimulation should be the maximum intensity that can be tolerated by the individual producing the joint movement.

Interventions/Control_2

Intervention 2: 4 minutes of energization under 70 Hz conditions, followed by dorsiflexion. The rhythm of the energization consists of 2 seconds of energization and 2 seconds of rest. This will be performed twice a week. The washout period will be 2 weeks. The intensity of the stimulation should be about the level of sensory energization, and joint movements should not be produced.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Hemiplegics were defined as having at least 3 lower extremities and 4 fingers at the Brunnstrom stage (BRS).

Key exclusion criteria

Patients with the following conditions were excluded. Those with peripheral neuropathy, Mini Mental State Examination (MMSE) scores of 10 or less, and those with severe dementia who were unable to make decisions on their own regarding cooperation in the study.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Masaya
Middle name
Last name Tanabe

Organization

Gunma PAZ University

Division name

Department of Physical Therapy, Faculty of Rehabilitation

Zip code

370-0006

Address

1-7-1 Tonyamachi, Takasaki City, Gunma Prefecture

TEL

0273653366

Email

tanabe@paz.ac.jp


Public contact

Name of contact person

1st name Masaya
Middle name
Last name Tanabe

Organization

Gunma PAZ University

Division name

Department of Physical Therapy, Faculty of Rehabilitation

Zip code

3700006

Address

1-7-1 Tonyamachi, Takasaki City, Gunma Prefecture

TEL

0273653366

Homepage URL


Email

tanabe@paz.ac.jp


Sponsor or person

Institute

Gunma PAZ University

Institute

Department

Personal name

TanabeMasaya


Funding Source

Organization

Gunma PAZ University

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma Perth University Ethics Review Committee

Address

1-7-1 Tonyamachi, Takasaki City, Gunma Prefecture

Tel

0273653366

Email

tanabe@paz.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 05 Month 22 Day

Date of IRB


Anticipated trial start date

2023 Year 06 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 06 Month 07 Day

Last modified on

2023 Year 06 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058128


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name